StonvexLoading…
StonvexStonvexStonvexCore line items from LMND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $258.00M | $737.90M | $509.80M | $315.30M |
Operating Income | $-34.60M | $-160.90M | $-140.30M | $-104.00M |
Net Income | $-35.80M | $-165.50M | $-143.80M | $-43.90M |
EPS (Diluted) | $-0.47 | $-2.24 | $-1.96 | $-1.45 |
Total Assets | $1.96B | $1.93B | $1.92B | $1.93B |
Total Liabilities | $1.44B | $1.39B | $1.40B | $1.41B |
Cash & Equivalents | $374.30M | $385.00M | $345.90M | $377.50M |
Free Cash Flow OCF − CapEx | $-4.10M | $-25.90M | $-43.50M | $-46.10M |
Shares Outstanding | 76.79M | 75.91M | 74.67M | 73.82M |